Jump to content
Powered by
  • Industry report The healthcare industry in Baden-Württemberg

    BIOPRO's new report entitled "Healthcare Industry 2020: Facts and Figures for Baden-Württemberg" illustrates key figures like num the number of companies, number of employees and taxable turnover for the biotechnology, medical technology and pharmaceutical industry.

  • Contact Stay in touch

    Would you like continue receiving e-mail notifications about our activities, up-to-date information, events, opportunities for cooperation and general industry information? Register here to stay informed about current issues.

  • Dossier Vaccines – a beacon of hope in the fight against pandemics

    Vaccines are an important technology in the fight against pandemics – learn more!

Biological and Digital Transformation

Freiburg & online

It is time again: BIOPRO Baden-Württemberg invites you to join our major networking meeting for the healthcare industry in Baden-Württemberg including the branches of medical technology, biotechnology and pharmaceutical industry taking place on the 16th of September 2021. You can expect a comprehensive conference programme on trends, new technologies and insights into interesting R&D projects. Meet us in Freiburg or join online!

Latest news

  • Press release - 13/10/2021

    EMBL scientists pave the way for reducing the harmful side effects antibiotics have on gut bacteria. Antibiotics help us to treat bacterial infections and save millions of lives each year. But they can also harm the helpful microbes residing in our gut, weakening one of our body’s first lines of defence against pathogens and compromising the multiple beneficial effects our microbiota has for our health.

  • Press release - 12/10/2021

    CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced the strategic decision to focus its COVID-19 vaccine development towards the development of second-generation mRNA vaccine candidates in collaboration with GSK and to withdraw its first-generation COVID-19 vaccine candidate, CVnCoV, from the current approval process.

  • Optimised peptides against infections and cancer - 07/10/2021

    Peptides are increasingly coming into scientific focus for application in diagnostics and therapy. The human body is full of these protein fragments, but only a fraction have been characterised. So there is enormous potential for discovering new biologically active substances that can help in the fight against bacteria, viruses and cancer. A collaborative research centre at Ulm University Hospital is on the trail of these promising fragments.

Website address: https://www.gesundheitsindustrie-bw.de/en